These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10856513)

  • 1. Therapeutic evaluation of free and liposome-encapsulated atovaquone in the treatment of murine leishmaniasis.
    Cauchetier E; Paul M; Rivollet D; Fessi H; Astier A; Deniau M
    Int J Parasitol; 2000 May; 30(6):777-83. PubMed ID: 10856513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic evaluation of free and nanocapsule-encapsulated atovaquone in the treatment of murine visceral leishmaniasis.
    Cauchetier E; Paul M; Rivollet D; Fessi H; Astier A; Deniau M
    Ann Trop Med Parasitol; 2003 Apr; 97(3):259-68. PubMed ID: 12803857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of pentamidine-loaded methacrylate nanoparticles against Leishmania infantum in a mouse model.
    Durand R; Paul M; Rivollet D; Houin R; Astier A; Deniau M
    Int J Parasitol; 1997 Nov; 27(11):1361-7. PubMed ID: 9421724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of oral atovaquone alone and in combination with antimony in experimental visceral leishmaniasis.
    Murray HW; Hariprashad J
    Antimicrob Agents Chemother; 1996 Mar; 40(3):586-7. PubMed ID: 8851575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi.
    Reimão JQ; Colombo FA; Pereira-Chioccola VL; Tempone AG
    Exp Parasitol; 2012 Mar; 130(3):195-9. PubMed ID: 22281156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.
    Gangneux JP; Sulahian A; Garin YJ; Farinotti R; Derouin F
    Antimicrob Agents Chemother; 1996 May; 40(5):1214-8. PubMed ID: 8723469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid formulations of amphotericin b in the treatment of experimental visceral leishmaniasis due to Leishmania infantum.
    Gangneux JP; Sulahian A; Garin YJ; Derouin F
    Trans R Soc Trop Med Hyg; 1996; 90(5):574-7. PubMed ID: 8944278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
    Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
    Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of water extract of green propolis and liposomal meglumine antimoniate in the treatment of experimental visceral leishmaniasis.
    Ferreira FM; Castro RA; Batista MA; Rossi FM; Silveira-Lemos D; Frézard F; Moura SA; Rezende SA
    Parasitol Res; 2014 Feb; 113(2):533-43. PubMed ID: 24292604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of pentamidine-loaded poly (D,L-lactide) nanoparticles against Leishmania infantum in a murine model.
    Durand R; Paul M; Rivollet D; Fessi H; Houin R; Astier A; Deniau M
    Parasite; 1997 Dec; 4(4):331-6. PubMed ID: 9587601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoliposomal Buparvaquone Immunomodulates Leishmania infantum-Infected Macrophages and Is Highly Effective in a Murine Model.
    da Costa-Silva TA; Galisteo AJ; Lindoso JA; Barbosa LR; Tempone AG
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of reference antileishmanial agents in murine visceral leishmaniasis due to Leishmania infantum.
    Buffet PA; Garin YJ; Sulahian A; Nassar N; Derouin F
    Ann Trop Med Parasitol; 1996 Jun; 90(3):295-302. PubMed ID: 8758143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic evaluation of free and liposome-loaded furazolidone in experimental visceral leishmaniasis.
    Tempone AG; Mortara RA; de Andrade HF; Reimão JQ
    Int J Antimicrob Agents; 2010 Aug; 36(2):159-63. PubMed ID: 20554161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemisynthetic trifluralin analogues incorporated in liposomes for the treatment of leishmanial infections.
    Carvalheiro M; Esteves MA; Santos-Mateus D; Lopes RM; Rodrigues MA; Eleutério CV; Scoulica E; Santos-Gomes G; Cruz ME
    Eur J Pharm Biopharm; 2015 Jun; 93():346-52. PubMed ID: 25936854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of visceral leishmaniasis with sterically stabilized liposomes containing camptothecin.
    Proulx ME; Désormeaux A; Marquis JF; Olivier M; Bergeron MG
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2623-7. PubMed ID: 11502539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
    Everlien H; Hockertz S
    Arzneimittelforschung; 1999 Nov; 49(11):954-61. PubMed ID: 10604050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine H1-receptor antagonists against Leishmania (L.) infantum: an in vitro and in vivo evaluation using phosphatidylserine-liposomes.
    Pinto EG; da Costa-Silva TA; Tempone AG
    Acta Trop; 2014 Sep; 137():206-10. PubMed ID: 24905294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of aminosidine administered alone or in combination with meglumine antimoniate for the treatment of experimental visceral leishmaniasis caused by Leishmania infantum.
    Gangneux JP; Sulahian A; Garin YJ; Derouin F
    J Antimicrob Chemother; 1997 Aug; 40(2):287-9. PubMed ID: 9301998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed formulation of conventional and pegylated liposomes as a novel drug delivery strategy for improved treatment of visceral leishmaniasis.
    Azevedo EG; Ribeiro RR; da Silva SM; Ferreira CS; de Souza LE; Ferreira AA; de Oliveira E Castro RA; Demicheli C; Rezende SA; Frézard F
    Expert Opin Drug Deliv; 2014 Oct; 11(10):1551-60. PubMed ID: 24962630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of mannosylated liposome incorporated benzyl derivative of Penicillium nigricans derived compound MT81 to reticuloendothelial systems for the treatment of visceral leishmaniasis.
    Mitra M; Mandal AK; Chatterjee TK; Das N
    J Drug Target; 2005 Jun; 13(5):285-93. PubMed ID: 16199372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.